Who owns RYTM? 13F holders and whale ownership
RYTM is tracked across public portfolios in Whale Analyzer. This page answers who owns RYTM, which top funds are buying RYTM, aggregate disclosed value, and recent position changes based on public data.
Open interactive stock dashboardTop holders
| Investor | Reported value | Shares | Change |
|---|---|---|---|
| Peter Kolchinsky 13F portfolio RA Capital Management holdings | $579.8M | 6.7M | Held |
| Baker Bros. Advisors 13F portfolio Baker Bros. Advisors holdings | $487.4M | 5.6M | Held |
| PRIMECAP Management 13F portfolio PRIMECAP Management Company holdings | $297.2M | 3.4M | Reduced |
| Joseph Edelman 13F portfolio Perceptive Advisors holdings | $206.4M | 2.4M | Reduced |
| Samuel Isaly 13F portfolio OrbiMed Advisors holdings | $27.3M | 314.1K | Increased |
How to read this page
Values are reported public positions from tracked investors and institutions. They are not real-time ownership totals for the company.
Related stock holder pages
- ASND whale holders — ASCENDIS PHARMA A/S - ADR
- PCVX whale holders — VAXCYTE INC
- TYRA whale holders — TYRA BIOSCIENCES INC
- SION whale holders — SIONNA THERAPEUTICS INC
- EWTX whale holders — EDGEWISE THERAPEUTICS INC
- NAMSW whale holders — NEWAMSTERDAM PHARMA CO NV
- NUVL whale holders — NUVALENT INC-A
- DNTH whale holders — DIANTHUS THERAPEUTICS INC
Learn more in Whale Analyzer Academy
Frequently asked questions
Who owns RYTM stock?
Whale Analyzer tracks 5 public institutional holders of RYTM with a combined reported value of $1.60B. See the holder table above for the largest tracked positions.
Which top funds are buying RYTM?
Check the "Change" column in the holders table above. "New" means a fresh position was initiated, "Added" means an existing position was increased, and "Reduced" or "Sold" indicates trimming.
What does 13F ownership mean for RYTM?
Use the interactive RYTM dashboard on Whale Analyzer for real-time holder analysis, or read our 13F Alpha Signals Guide.